Saudi approves Sinovac and Sinopharm vaccines
Saudi Arabia on Tuesday approved two further COVID-19 vaccines, Sinovac and Sinopharm. There are currently four vaccines approved for use in the Kingdom: Oxford-AstraZeneca, Pfizer-BioNTech, Johnson & Johnson, and Moderna.
The Ministry of Health said it was possible for those who had completed their vaccination program with Sinopharm or Sinovac to be accepted in the Kingdom, provided they had received a booster shot of a vaccine that was approved in the country.
It previously said that two doses of two different vaccines could be taken, according to international scientific studies that showed the safety and effectiveness of this approach in addressing the virus.
It added that, according to current recommendations, the second dose could be taken at least three weeks after the first.
